Once prescribed, the platform automates insurance approval and pharmacy fulfillment while providing the patient with continuous coaching and side-effect monitoring via a mobile app
In November 2023, it was approved again under the brand name Zepbound for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition
Assessment of clinical signs of atopic dermatitis: A systematic review and recommendation
Results of limited research studies are promising in human studies
Most bruises associated with semaglutide injections are small (less than one inch in diameter), painless or mildly tender, and resolve within 7-14 days without treatment
Ethics declarations Conflict of interest All authors (Jos Pablo Miramontes-Gonzlez, lvaro Rodrigo-Alaz, Miriam Gabella-Martn, David Gonzlez-Calle, Juana Carretero-Gmez and Luis Corral-Gudino) have nothing to disclose